Thomas Martin

4.3k total citations
86 papers, 1.4k citations indexed

About

Thomas Martin is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Thomas Martin has authored 86 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 43 papers in Hematology and 19 papers in Molecular Biology. Recurrent topics in Thomas Martin's work include Multiple Myeloma Research and Treatments (31 papers), CAR-T cell therapy research (27 papers) and Protein Degradation and Inhibitors (10 papers). Thomas Martin is often cited by papers focused on Multiple Myeloma Research and Treatments (31 papers), CAR-T cell therapy research (27 papers) and Protein Degradation and Inhibitors (10 papers). Thomas Martin collaborates with scholars based in United States, Spain and France. Thomas Martin's co-authors include Joan A. Smyth, Sandy W. Wong, Nina Shah, Chiung‐Yu Huang, Jeffrey L. Wolf, James Gajewski, Raymond J. Roberge, Mimi Lo, Lloyd E. Damon and Ying Sheng and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas Martin

82 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Martin United States 23 565 532 453 193 183 86 1.4k
Peter Meyer Germany 20 222 0.4× 516 1.0× 430 0.9× 112 0.6× 94 0.5× 51 1.8k
Yijun Yang United States 24 252 0.4× 199 0.4× 634 1.4× 103 0.5× 70 0.4× 56 1.9k
G Mathé France 18 392 0.7× 403 0.8× 285 0.6× 371 1.9× 173 0.9× 105 1.4k
G. A. R. Young Australia 15 386 0.7× 226 0.4× 216 0.5× 72 0.4× 175 1.0× 48 985
C Bunch United Kingdom 20 559 1.0× 168 0.3× 226 0.5× 392 2.0× 345 1.9× 47 1.5k
İrfan Kuku Türkiye 18 249 0.4× 151 0.3× 124 0.3× 81 0.4× 65 0.4× 95 983
Davor Brinc Canada 19 337 0.6× 92 0.2× 282 0.6× 323 1.7× 85 0.5× 54 1.5k
Yutaka Saikawa Japan 19 227 0.4× 235 0.4× 480 1.1× 164 0.8× 114 0.6× 57 1.2k
Xavier Tréton France 27 87 0.2× 261 0.5× 591 1.3× 469 2.4× 132 0.7× 105 2.5k
Joanna Matowicka-Karna Poland 20 106 0.2× 281 0.5× 258 0.6× 148 0.8× 46 0.3× 88 1.2k

Countries citing papers authored by Thomas Martin

Since Specialization
Citations

This map shows the geographic impact of Thomas Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Martin more than expected).

Fields of papers citing papers by Thomas Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Martin. The network helps show where Thomas Martin may publish in the future.

Co-authorship network of co-authors of Thomas Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Martin. A scholar is included among the top collaborators of Thomas Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Martin. Thomas Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ledergor, Guy, Kaichun Wu, Elizabeth McCarthy, et al.. (2024). CD4+ CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy. Blood Advances. 8(13). 3562–3575. 19 indexed citations
2.
Varney, Shawn M., Mark L. Winter, Thomas Martin, et al.. (2024). An Analysis of Clinical Outcomes of Exploratory Pediatric Metformin Ingestions Reported to the Texas Poison Center Network From 2011 to 2021. Hospital Pharmacy. 59(4). 465–470.
3.
Reyes, Kevin, Chiung‐Yu Huang, Mimi Lo, et al.. (2023). Safety and Efficacy of BCMA CAR-T Cell Therapy in Older Patients With Multiple Myeloma. Transplantation and Cellular Therapy. 29(6). 350–355. 26 indexed citations
4.
Lin, Yi, Thomas Martin, Saad Z. Usmani, et al.. (2023). POSTER: MM-309 CARTITUDE-1 Final Results: Phase 1b/2 Study of Ciltacabtagene Autoleucel in Heavily Pretreated Patients With Relapsed/Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 23. S226–S226. 1 indexed citations
5.
Huang, Li‐Wen, Ying Shi, Charalambos Andreadis, et al.. (2023). Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults. Journal of Geriatric Oncology. 14(8). 101623–101623. 5 indexed citations
6.
Martin, Thomas, Carolyn C. Jackson, Lida Pacaud, Deepu Madduri, & Sundar Jagannath. (2022). Recent Advances in the Use of Chimeric Antigen Receptor–Expressing T-Cell Therapies for Treatment of Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 23(1). 22–27. 6 indexed citations
7.
Kım, Kihyun, Chang‐Ki Min, Youngil Koh, et al.. (2022). Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis. International Journal of Hematology. 116(4). 553–562. 3 indexed citations
8.
Martin, Thomas, et al.. (2022). EE167 Use of Cost per Responder Models for CAR-T Therapies in Relapsed or Refractory Multiple Myeloma. Value in Health. 25(7). S366–S366. 1 indexed citations
9.
Kambhampati, Swetha, Ying Sheng, Chiung‐Yu Huang, et al.. (2021). Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy. Blood Advances. 6(7). 2045–2054. 79 indexed citations
10.
Banerjee, Rahul, Chiung‐Yu Huang, Mimi Lo, et al.. (2021). Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma. Transplantation and Cellular Therapy. 27(6). 477.e1–477.e7. 27 indexed citations
11.
Kambhampati, Swetha, Bita Fakhri, Ying Sheng, et al.. (2020). Infectious Complications of BCMA-Targeted and CD19-Targeted Chimeric Antigen Receptor T-Cell Immunotherapy. Blood. 136(Supplement 1). 4–5. 10 indexed citations
12.
Tian, Ruilin, Priya Choudhry, Torsten Hechler, et al.. (2020). CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma. Blood Advances. 4(13). 2899–2911. 37 indexed citations
13.
Sheng, Ying, Chiung‐Yu Huang, Charalambos Andreadis, et al.. (2020). Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation. Journal of Geriatric Oncology. 12(4). 531–539. 4 indexed citations
14.
Tan, Marisela, Evan Kalin-Hajdu, Rupa Narayan, Sandy W. Wong, & Thomas Martin. (2018). Zoledronic acid-induced orbital inflammation in a patient with multiple myeloma. Journal of Oncology Pharmacy Practice. 25(5). 1253–1257. 4 indexed citations
15.
Keller, Jesse W., Charalambos Andreadis, Lloyd E. Damon, et al.. (2014). Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients. Journal of Geriatric Oncology. 5(3). 238–244. 10 indexed citations
16.
Dehghan, Mohammad Hossein, et al.. (2005). Antifertility effect of Iranian neem seed alcoholic extract on epididymal sperm of mice. International Journal of Reproductive BioMedicine (IJRM). 3(2). 83–89. 18 indexed citations
17.
Martin, Thomas, et al.. (2002). Influence Of Perceived Stress On Delayed Onset Pain Episodes And Related Functional Changes In Complex Regional Pain Syndrome Patients... Platform & Poster Presentations For Csm 2003. Journal of Neurologic Physical Therapy. 26(4).
18.
Albertson, Timothy E., Andrew Dawson, Robert S. Hoffman, et al.. (2001). TOX-ACLS: Toxicologic-oriented advanced cardiac life support. Annals of Emergency Medicine. 37(4). S78–S90. 85 indexed citations
19.
Martin, Thomas & James Gajewski. (2001). Allogeneic Stem Cell Transplantation for Acute Lymphocytic Leukemia in Adults. Hematology/Oncology Clinics of North America. 15(1). 97–120. 25 indexed citations
20.
Roberge, Raymond J., Thomas Martin, & Theodore R. Delbridge. (1993). Intentional massive insulin overdose: Recognition and management. Annals of Emergency Medicine. 22(2). 228–234. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Meyer Breakdown of academic impact, for papers by Yijun Yang Breakdown of academic impact, for papers by G Mathé Breakdown of academic impact, for papers by G. A. R. Young Breakdown of academic impact, for papers by C Bunch Breakdown of academic impact, for papers by İrfan Kuku Breakdown of academic impact, for papers by Davor Brinc Breakdown of academic impact, for papers by Yutaka Saikawa Breakdown of academic impact, for papers by Xavier Tréton Breakdown of academic impact, for papers by Joanna Matowicka-Karna
Rankless by CCL
2026